During RA activity, FLS produces a multitude of angiogenic factors, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which pathologically alter endothelial cell activity and promote joint angiogenesis. This evidence concerns the gene VEGFA and rheumatoid arthritis.